PharmaSGP Holding SE Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Aug '25 Aug 8, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Last Close Price	-	24.16	20.31	23.18	22.47	22.75	Upgrade
Debt / Equity Ratio	1.81	2.08	1.86	2.64	3.84	0.03	Upgrade
Debt / EBITDA Ratio	1.77	1.80	2.19	3.06	4.63	0.02	Upgrade
Debt / FCF Ratio	3.00	2.68	2.78	3.33	7.01	0.03	Upgrade
Asset Turnover	0.94	0.97	0.78	0.70	0.93	0.98	Upgrade
Inventory Turnover	1.16	1.06	1.11	1.62	1.80	2.42	Upgrade
Quick Ratio	2.09	1.74	2.04	1.85	0.30	1.46	Upgrade
Current Ratio	2.68	2.33	2.55	2.27	0.35	1.72	Upgrade
Return on Equity (ROE)	48.46%	54.48%	46.29%	44.86%	63.43%	19.87%	Upgrade
Return on Assets (ROA)	13.58%	14.07%	11.83%	9.08%	13.40%	15.06%	Upgrade
Return on Capital (ROIC)	15.88%	16.29%	13.58%	10.06%	15.74%	17.99%	Upgrade
Return on Capital Employed (ROCE)	29.40%	30.30%	23.10%	16.70%	66.70%	130.20%	Upgrade
Dividend Yield	0.17%	2.11%	6.70%	2.11%	2.00%	-	Upgrade
Payout Ratio	82.75%	83.48%	35.83%	45.17%	-	891.29%	Upgrade
Buyback Yield / Dilution	2.24%	0.99%	0.06%	-	-	-	Upgrade
Total Shareholder Return	2.41%	3.10%	6.76%	2.11%	2.00%	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.